← Evidence map

ArticleeLife2022

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines.

Sara Feola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35314027